UMN Pharma Owners | StatInvestor

Health Care & Life Sciences » Biotechnology | UMN Pharma Inc.

UMN Pharma Inc. | Ownership

Name

Shares Held

% Shares Out

Change In Shares

% of Assets

As of Date

GO ETF Solutions LLP

39,643

0.31%

39,643

0.01%

02/28/2018

Siemens Fonds Invest GmbH

36,499

0.28%

1,100

0.01%

04/30/2018

Meiji Yasuda Asset Management Co. Ltd.

-6,300

02/15/2017

Asset Management One Co., Ltd.

-39,000

04/17/2017

FIL Investments (Japan) Ltd.

-7,400

11/30/2016

View Profile

Address	4-2-3 Gosyonoyumoto Akita Akita 010 Japan
Employees	-
Website	http://www.umnpharma.com
Updated	07/08/2019
UMN Pharma, Inc. engages in the development, manufacture, and sale of biopharmaceuticals. It develops vaccines targeting influenza, norovirus, and rotavirus. The company was founded by Masahiro Michishita and Shuichi Kanazashi on April 20, 2004 and is headquartered in Akita, Japan.